Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.
Viveve Medical Stock Performance
NASDAQ:VIVE traded down $0.02 during midday trading on Friday, reaching $0.80. The stock had a trading volume of 53,698 shares, compared to its average volume of 53,457. Viveve Medical has a 1-year low of $0.59 and a 1-year high of $3.08. The firm's fifty day simple moving average is $0.70 and its 200-day simple moving average is $0.85.
Viveve Medical (NASDAQ:VIVE - Get Rating) last posted its quarterly earnings results on Thursday, May 12th. The company reported ($0.67) earnings per share (EPS) for the quarter. The company had revenue of $1.64 million during the quarter. Viveve Medical had a negative return on equity of 165.42% and a negative net margin of 371.96%. On average, sell-side analysts anticipate that Viveve Medical will post -2.66 EPS for the current year.